131 related articles for article (PubMed ID: 34649077)
1. Deiodinase-3 is a thyrostat to regulate podocyte homeostasis.
Agarwal S; Koh KH; Tardi NJ; Chen C; Dande RR; WerneckdeCastro JP; Sudhini YR; Luongo C; Salvatore D; Samelko B; Altintas MM; Mangos S; Bianco A; Reiser J
EBioMedicine; 2021 Oct; 72():103617. PubMed ID: 34649077
[TBL] [Abstract][Full Text] [Related]
2. Alteration of thyroid hormone signaling triggers the diabetes-induced pathological growth, remodeling, and dedifferentiation of podocytes.
Benedetti V; Lavecchia AM; Locatelli M; Brizi V; Corna D; Todeschini M; Novelli R; Benigni A; Zoja C; Remuzzi G; Xinaris C
JCI Insight; 2019 Sep; 4(18):. PubMed ID: 31534055
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of rituximab on puromycin-induced apoptosis, loss of adhesion and cytoskeletal alterations in human podocytes.
Jeruschke S; Alex D; Hoyer PF; Weber S
Sci Rep; 2022 Jul; 12(1):12297. PubMed ID: 35853959
[TBL] [Abstract][Full Text] [Related]
4. Acute podocyte vascular endothelial growth factor (VEGF-A) knockdown disrupts alphaVbeta3 integrin signaling in the glomerulus.
Veron D; Villegas G; Aggarwal PK; Bertuccio C; Jimenez J; Velazquez H; Reidy K; Abrahamson DR; Moeckel G; Kashgarian M; Tufro A
PLoS One; 2012; 7(7):e40589. PubMed ID: 22808199
[TBL] [Abstract][Full Text] [Related]
5. Anti-ANGPTL3-FLD monoclonal antibody treatment ameliorates podocyte lesions through attenuating mitochondrial damage.
Lv Q; Han X; Ni J; Ma Q; Dai R; Liu J; Liu J; Zhai Y; Shen Q; Sun L; Liu H; Rao J; Xu H
Cell Death Dis; 2022 Oct; 13(10):867. PubMed ID: 36229446
[TBL] [Abstract][Full Text] [Related]
6. A novel splicing variant of small nucleolar RNA host gene 4 is a podocyte-selective non-coding RNA upregulated in response to puromycin aminonucleoside-induced podocyte injury.
Horikawa A; Yoneda T; Yaoita E; Yamaguchi K; Shigenobu S; Kuramochi M; Yamate J; Inui T; Ishibashi O
J Biochem; 2019 May; 165(5):447-454. PubMed ID: 30597036
[TBL] [Abstract][Full Text] [Related]
7. Modification of kidney barrier function by the urokinase receptor.
Wei C; Möller CC; Altintas MM; Li J; Schwarz K; Zacchigna S; Xie L; Henger A; Schmid H; Rastaldi MP; Cowan P; Kretzler M; Parrilla R; Bendayan M; Gupta V; Nikolic B; Kalluri R; Carmeliet P; Mundel P; Reiser J
Nat Med; 2008 Jan; 14(1):55-63. PubMed ID: 18084301
[TBL] [Abstract][Full Text] [Related]
8. Calcineurin inhibitors ameliorate PAN-induced podocyte injury through the NFAT-Angptl4 pathway.
Shen X; Zhang Y; Lin C; Weng C; Wang Y; Feng S; Wang C; Shao X; Lin W; Li B; Wang H; Chen J; Jiang H
J Pathol; 2020 Nov; 252(3):227-238. PubMed ID: 32686149
[TBL] [Abstract][Full Text] [Related]
9. Calcineurin inhibitors cyclosporin A and tacrolimus protect against podocyte injury induced by puromycin aminonucleoside in rodent models.
Shen X; Jiang H; Ying M; Xie Z; Li X; Wang H; Zhao J; Lin C; Wang Y; Feng S; Shen J; Weng C; Lin W; Wang H; Zhou Q; Bi Y; Li M; Wang L; Zhu T; Huang X; Lan HY; Zhou J; Chen J
Sci Rep; 2016 Sep; 6():32087. PubMed ID: 27580845
[TBL] [Abstract][Full Text] [Related]
10. β-Catenin regulates deiodinase levels and thyroid hormone signaling in colon cancer cells.
Dentice M; Luongo C; Ambrosio R; Sibilio A; Casillo A; Iaccarino A; Troncone G; Fenzi G; Larsen PR; Salvatore D
Gastroenterology; 2012 Oct; 143(4):1037-47. PubMed ID: 22771508
[TBL] [Abstract][Full Text] [Related]
11. The Thyroid Hormone Inactivator Enzyme, Type 3 Deiodinase, Is Essential for Coordination of Keratinocyte Growth and Differentiation.
Mancino G; Sibilio A; Luongo C; Di Cicco E; Miro C; Cicatiello AG; Nappi A; Sagliocchi S; Ambrosio R; De Stefano MA; Di Girolamo D; Porcelli T; Murolo M; Saracino F; Perruolo G; Formisano P; Stornaiuolo M; Dentice M
Thyroid; 2020 Jul; 30(7):1066-1078. PubMed ID: 32111151
[No Abstract] [Full Text] [Related]
12. Paracrine signaling by glial cell-derived triiodothyronine activates neuronal gene expression in the rodent brain and human cells.
Freitas BC; Gereben B; Castillo M; Kalló I; Zeöld A; Egri P; Liposits Z; Zavacki AM; Maciel RM; Jo S; Singru P; Sanchez E; Lechan RM; Bianco AC
J Clin Invest; 2010 Jun; 120(6):2206-17. PubMed ID: 20458138
[TBL] [Abstract][Full Text] [Related]
13. Loss of the podocyte glucocorticoid receptor exacerbates proteinuria after injury.
Zhou H; Tian X; Tufro A; Moeckel G; Ishibe S; Goodwin J
Sci Rep; 2017 Aug; 7(1):9833. PubMed ID: 28852159
[TBL] [Abstract][Full Text] [Related]
14. Fluvastatin ameliorates podocyte injury in proteinuric rats via modulation of excessive Rho signaling.
Shibata S; Nagase M; Fujita T
J Am Soc Nephrol; 2006 Mar; 17(3):754-64. PubMed ID: 16452496
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D down-regulates TRPC6 expression in podocyte injury and proteinuric glomerular disease.
Sonneveld R; Ferrè S; Hoenderop JG; Dijkman HB; Berden JH; Bindels RJ; Wetzels JF; van der Vlag J; Nijenhuis T
Am J Pathol; 2013 Apr; 182(4):1196-204. PubMed ID: 23385000
[TBL] [Abstract][Full Text] [Related]
16. Podocyte migration during nephrotic syndrome requires a coordinated interplay between cathepsin L and alpha3 integrin.
Reiser J; Oh J; Shirato I; Asanuma K; Hug A; Mundel TM; Honey K; Ishidoh K; Kominami E; Kreidberg JA; Tomino Y; Mundel P
J Biol Chem; 2004 Aug; 279(33):34827-32. PubMed ID: 15197181
[TBL] [Abstract][Full Text] [Related]
17. CD147/Basigin Deficiency Prevents the Development of Podocyte Injury through FAK Signaling.
Yoshioka T; Kosugi T; Masuda T; Watanabe T; Ryuge A; Nagaya H; Maeda K; Sato Y; Katsuno T; Kato N; Ishimoto T; Yuzawa Y; Maruyama S; Kadomatsu K
Am J Pathol; 2019 Jul; 189(7):1338-1350. PubMed ID: 31014956
[TBL] [Abstract][Full Text] [Related]
18. Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats.
Okada T; Sakaguchi T; Hatamura I; Saji F; Negi S; Otani H; Muragaki Y; Kawachi H; Shigematsu T
Clin Exp Nephrol; 2009 Oct; 13(5):438-446. PubMed ID: 19452240
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the protein kinase MK-2 protects podocytes from nephrotic syndrome-related injury.
Pengal R; Guess AJ; Agrawal S; Manley J; Ransom RF; Mourey RJ; Benndorf R; Smoyer WE
Am J Physiol Renal Physiol; 2011 Sep; 301(3):F509-19. PubMed ID: 21613416
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein modulation of proteinuric renal injury.
Tsuchida Y; Zhong J; Otsuka T; Dikalova A; Pastan I; Anantharamaiah GM; Linton MF; Yancey PG; Ikizler TA; Fogo AB; Yang H; Kon V
Lab Invest; 2019 Jul; 99(8):1107-1116. PubMed ID: 31019291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
